0001648315-15-000001.txt : 20150717 0001648315-15-000001.hdr.sgml : 20150717 20150717083958 ACCESSION NUMBER: 0001648315-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150717 DATE AS OF CHANGE: 20150717 EFFECTIVENESS DATE: 20150717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HLS Therapeutics Inc. CENTRAL INDEX KEY: 0001648315 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-243945 FILM NUMBER: 15992796 BUSINESS ADDRESS: STREET 1: 17474 HUMBER STATION ROAD CITY: CALEDON STATE: A6 ZIP: L7E 0Z2 BUSINESS PHONE: 416-624-6568 MAIL ADDRESS: STREET 1: 17474 HUMBER STATION ROAD CITY: CALEDON STATE: A6 ZIP: L7E 0Z2 D 1 primary_doc.xml X0707 D LIVE 0001648315 HLS Therapeutics Inc. 17474 HUMBER STATION ROAD CALEDON A6 ONTARIO, CANADA L7E 0Z2 416-624-6568 BRITISH COLUMBIA, CANADA None None Corporation true 2014 Gregory D Gubitz c/o HLS Therapeutics Inc. 17474 Humber Station Road Caledon A6 ONTARIO, CANADA L7E 0Z2 Executive Officer Director Bill Wells c/o HLS Therapeutics Inc. 17474 Humber Station Road Caledon A6 ONTARIO, CANADA L7E 0Z2 Director Gilbert Godin c/o HLS Therapeutics Inc. 17474 Humber Station Road Caledon A6 ONTARIO, CANADA L7E 0Z2 Executive Officer Director Joseph MacLean c/o HLS Therapeutics Inc. 17474 Humber Station Road Caledon A6 ONTARIO, CANADA L7E 0Z2 Executive Officer Director Chris Fibiger c/o HLS Therapeutics Inc. 17474 Humber Station Road Caledon A6 ONTARIO, CANADA L7E 0Z2 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2015-07-02 false true true false 25000 GMP Securities, LLC 41025 None None 530 Fifth Avenue, 15th Floor New York NY NEW YORK 10036 AZ ARIZONA CO COLORADO CT CONNECTICUT FL FLORIDA NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA TX TEXAS false 112787710 112787710 0 false 22 59100000 0 0 false HLS Therapeutics Inc. /s/ Gregory D. Gubitz Gregory D. Gubitz CEO 2015-07-17